ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for SYRE

Stock NameSpyre Therapeutics Inc.
TickerSYRE(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate SYRE holdings

News associated with SYRE

Spyre Therapeutics (NASDAQ:SYRE) Upgraded by Wall Street Zen to “Hold” Rating
Wall Street Zen upgraded shares of Spyre Therapeutics (NASDAQ:SYRE – Free Report) from a sell rating to a hold rating in a research report sent to investors on Monday. Separately, Wedbush reiterated an “outperform” rating and issued a $65.00 price target on shares of Spyre Therapeutics in a research note on Wednesday, August 6th. Two […] - 2025-09-09 02:57:04
Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Price Target at $53.40
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are currently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price […] - 2025-09-08 02:32:51
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives $53.40 Average PT from Analysts
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has been given an average recommendation of “Buy” by the seven research firms that are covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1 year […] - 2025-08-14 02:31:05
XTX Topco Ltd Acquires Shares of 28,499 Spyre Therapeutics, Inc. (NASDAQ:SYRE)
XTX Topco Ltd acquired a new stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) in the first quarter, Holdings Channel reports. The institutional investor acquired 28,499 shares of the company’s stock, valued at approximately $460,000. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the […] - 2025-08-08 04:38:55
The Math Shows SCHA Can Go To $31
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 09:07:38
Victory Capital Management Inc. Lowers Holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Victory Capital Management Inc. decreased its holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 6.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 251,846 shares of the company’s stock after selling 16,230 shares during the quarter. Victory Capital Management Inc.’s […] - 2025-07-28 05:02:49
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Average Recommendation of “Buy” by Analysts
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has earned an average rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […] - 2025-07-17 05:10:58
122,153 Shares in Spyre Therapeutics, Inc. (NASDAQ:SYRE) Acquired by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 122,153 shares of the company’s stock, valued at approximately $2,844,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.24% […] - 2025-06-03 05:35:02
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 4.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 22,741 shares of the company’s stock after acquiring an additional 916 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Spyre Therapeutics […] - 2025-05-30 04:48:57
Analysts Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) PT at $49.57
Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ten brokerages that are presently covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average […] - 2025-05-06 02:32:52
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Shares Acquired by Barclays PLC
Barclays PLC lifted its position in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 16.7% in the fourth quarter, Holdings Channel reports. The firm owned 123,071 shares of the company’s stock after acquiring an additional 17,604 shares during the period. Barclays PLC’s holdings in Spyre Therapeutics were worth $2,866,000 as of its most recent filing […] - 2025-04-30 05:15:05
Legal & General Group Plc Has $873,000 Position in Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Legal & General Group Plc grew its holdings in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 14.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 37,490 shares of the company’s stock after purchasing an additional 4,824 shares during the quarter. […] - 2025-04-28 04:56:53
Vanguard Group Inc. Purchases 330,553 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Vanguard Group Inc. increased its position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 13.1% in the 4th quarter, HoldingsChannel reports. The fund owned 2,846,473 shares of the company’s stock after acquiring an additional 330,553 shares during the period. Vanguard Group Inc. owned approximately 0.06% of Spyre Therapeutics worth $66,266,000 as of […] - 2025-04-11 05:40:57
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives $50.33 Average Price Target from Brokerages
Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) have received an average rating of “Buy” from the ten analysts that are covering the stock, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month target price […] - 2025-04-11 02:54:51
Corebridge Financial Inc. Sells 1,299 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Corebridge Financial Inc. lowered its stake in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 7.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 17,213 shares of the company’s stock after selling 1,299 shares during the period. Corebridge Financial Inc.’s holdings in Spyre Therapeutics […] - 2025-04-10 04:49:04
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Shares Acquired by Wellington Management Group LLP
Wellington Management Group LLP increased its position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 6.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,604,508 shares of the company’s stock after acquiring an additional 97,308 shares during the quarter. Wellington Management Group LLP’s holdings in Spyre Therapeutics were worth $37,353,000 […] - 2025-04-07 06:35:09
Schroder Investment Management Group Takes $2.56 Million Position in Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Schroder Investment Management Group bought a new position in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 113,620 shares of the company’s stock, valued at approximately $2,561,000. Schroder Investment Management Group owned about 0.22% of Spyre […] - 2025-04-07 05:10:58
Natixis Advisors LLC Invests $403,000 in Spyre Therapeutics, Inc. (NASDAQ:SYRE)
Natixis Advisors LLC bought a new position in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) during the fourth quarter, Holdings Channel reports. The firm bought 17,300 shares of the company’s stock, valued at approximately $403,000. Several other large investors have also added to or reduced their stakes in SYRE. Barclays PLC increased its holdings in […] - 2025-03-28 06:04:54
Wolfe Research Initiates Coverage on Spyre Therapeutics (NASDAQ:SYRE)
Wolfe Research assumed coverage on shares of Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) in a research report issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $27.00 price target on the stock. Wolfe Research’s price objective suggests a potential upside of 46.74% from the company’s previous close. Several other equities […] - 2025-03-20 04:22:57
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Receives Average Rating of “Buy” from Analysts
Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-03-14 04:25:02

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc SYRE holdings

DateNumber of SYRE Shares HeldBase Market Value of SYRE SharesLocal Market Value of SYRE SharesChange in SYRE Shares HeldChange in SYRE Base ValueCurrent Price per SYRE Share HeldPrevious Price per SYRE Share Held
2025-12-15 (Monday)18,118USD 604,054SYRE holding decreased by -5073USD 604,0540USD -5,073 USD 33.34 USD 33.62
2025-12-12 (Friday)18,118USD 609,127SYRE holding decreased by -13407USD 609,1270USD -13,407 USD 33.62 USD 34.36
2025-12-11 (Thursday)18,118USD 622,534SYRE holding decreased by -5436USD 622,5340USD -5,436 USD 34.36 USD 34.66
2025-12-10 (Wednesday)18,118USD 627,970SYRE holding increased by 17756USD 627,9700USD 17,756 USD 34.66 USD 33.68
2025-12-09 (Tuesday)18,118USD 610,214SYRE holding decreased by -17212USD 610,2140USD -17,212 USD 33.68 USD 34.63
2025-12-08 (Monday)18,118USD 627,426SYRE holding increased by 21379USD 627,4260USD 21,379 USD 34.63 USD 33.45
2025-12-05 (Friday)18,118USD 606,047SYRE holding decreased by -1087USD 606,0470USD -1,087 USD 33.45 USD 33.51
2025-12-04 (Thursday)18,118USD 607,134SYRE holding increased by 23734USD 607,1340USD 23,734 USD 33.51 USD 32.2
2025-12-03 (Wednesday)18,118SYRE holding decreased by -315USD 583,400SYRE holding increased by 59903USD 583,400-315USD 59,903 USD 32.2 USD 28.4
2025-12-02 (Tuesday)18,433SYRE holding increased by 126USD 523,497SYRE holding decreased by -1182USD 523,497126USD -1,182 USD 28.4 USD 28.66
2025-12-01 (Monday)18,307USD 524,679SYRE holding decreased by -24531USD 524,6790USD -24,531 USD 28.66 USD 30
2025-11-28 (Friday)18,307USD 549,210SYRE holding increased by 4577USD 549,2100USD 4,577 USD 30 USD 29.75
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SYRE by Blackrock for IE00B3VWM098

Show aggregate share trades of SYRE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-315 32.200* 20.49 Profit of 6,455 on sale
2025-12-02BUY126 28.400* 20.46
2025-11-25SELL-189 29.200* 20.24 Profit of 3,825 on sale
2025-11-24SELL-4,400 26.970* 20.20 Profit of 88,891 on sale
2025-11-17SELL-858 24.360* 20.10 Profit of 17,250 on sale
2025-11-12SELL-78 23.430* 20.06 Profit of 1,564 on sale
2025-11-06SELL-78 22.390* 20.00 Profit of 1,560 on sale
2025-11-05SELL-78023.50022.030 22.177USD -17,298 19.99 Loss of -1,706 on sale
2025-11-04SELL-156 22.980* 19.97 Profit of 3,116 on sale
2025-11-03SELL-15624.45022.475 22.673USD -3,537 19.95 Loss of -424 on sale
2025-10-28BUY23424.64025.055 25.014USD 5,853 19.86
2025-10-24SELL-7823.37023.590 23.568USD -1,838 19.81 Loss of -293 on sale
2025-10-15BUY46822.19022.305 22.294USD 10,433 19.70
2025-10-02BUY7815.98016.700 16.628USD 1,297 19.75
2025-09-30BUY15616.76016.790 16.787USD 2,619 19.78
2025-08-21SELL-7816.78016.910 16.897USD -1,318 19.90 Profit of 234 on sale
2025-07-31BUY23416.97017.317 17.282USD 4,044 19.94
2025-06-30SELL-15614.97015.840 15.753USD -2,457 20.42 Profit of 728 on sale
2025-06-25SELL-7815.72015.890 15.873USD -1,238 20.52 Profit of 363 on sale
2025-06-20SELL-15615.01015.275 15.248USD -2,379 20.64 Profit of 841 on sale
2025-05-23BUY7815.01015.110 15.100USD 1,178 21.38
2025-05-19SELL-7814.88015.550 15.483USD -1,208 21.60 Profit of 477 on sale
2025-05-15SELL-23414.54014.860 14.828USD -3,470 21.71 Profit of 1,611 on sale
2025-05-12SELL-7814.93015.570 15.506USD -1,209 21.90 Profit of 499 on sale
2025-05-09SELL-7814.10014.800 14.730USD -1,149 21.97 Profit of 565 on sale
2025-04-30SELL-7815.23015.450 15.428USD -1,203 22.52 Profit of 553 on sale
2025-04-24SELL-15614.93014.990 14.984USD -2,338 22.84 Profit of 1,225 on sale
2025-04-17SELL-7812.67012.790 12.778USD -997 23.34 Profit of 824 on sale
2025-04-15SELL-23412.71013.285 13.227USD -3,095 23.57 Profit of 2,421 on sale
2025-04-14SELL-23413.02013.100 13.092USD -3,064 23.69 Profit of 2,479 on sale
2025-04-09SELL-31213.37013.760 13.721USD -4,281 24.07 Profit of 3,229 on sale
2025-04-07SELL-54612.39013.230 13.146USD -7,178 24.35 Profit of 6,116 on sale
2025-04-04BUY6,01712.79013.630 13.546USD 81,506 24.48
2025-03-31BUY5716.13517.675 17.521USD 999 24.81
2025-03-19SELL-11418.40018.820 18.778USD -2,141 25.54 Profit of 770 on sale
2025-03-14SELL-34218.04018.985 18.891USD -6,461 25.85 Profit of 2,379 on sale
2025-03-13SELL-11418.03018.995 18.899USD -2,154 25.96 Profit of 805 on sale
2025-03-12SELL-1,93818.88019.440 19.384USD -37,566 26.06 Profit of 12,941 on sale
2025-03-07SELL-11419.49021.030 20.876USD -2,380 26.39 Profit of 628 on sale
2025-03-06SELL-17120.50020.570 20.563USD -3,516 26.48 Profit of 1,011 on sale
2025-03-03SELL-5717.94020.000 19.794USD -1,128 26.86 Profit of 403 on sale
2025-02-28SELL-34219.70019.975 19.948USD -6,822 26.98 Profit of 2,405 on sale
2025-02-26SELL-5719.00021.500 21.250USD -1,211 27.26 Profit of 343 on sale
2025-02-25SELL-17120.65021.500 21.415USD -3,662 27.37 Profit of 1,019 on sale
2025-02-18BUY28522.07023.600 23.447USD 6,682 27.89
2025-02-13BUY5722.68023.750 23.643USD 1,348 28.20
2025-02-12BUY5723.27023.350 23.342USD 1,330 28.30
2025-02-11BUY17122.15022.750 22.690USD 3,880 28.42
2025-02-06BUY51323.86024.348 24.299USD 12,465 28.78
2025-01-27BUY5720.82022.810 22.611USD 1,289 30.14
2024-12-30BUY28522.54023.440 23.350USD 6,655 31.07
2024-12-06BUY22827.08027.190 27.179USD 6,197 31.50
2024-12-05BUY5725.55027.920 27.683USD 1,578 31.70
2024-12-04BUY28527.99028.180 28.161USD 8,026 31.84
2024-11-29BUY28528.43028.550 28.538USD 8,133 32.32
2024-11-27BUY22827.75028.225 28.178USD 6,424 32.72
2024-11-26BUY5727.83028.460 28.397USD 1,619 32.94
2024-11-25BUY4,22827.81028.360 28.305USD 119,674 33.19
2024-11-21BUY22027.00029.090 28.881USD 6,354 33.80
2024-11-20BUY13227.50028.480 28.382USD 3,746 34.15
2024-11-18BUY52828.67030.340 30.173USD 15,931 34.95
2024-11-12BUY35235.82040.260 39.816USD 14,015 34.89
2024-11-08BUY22039.57539.630 39.625USD 8,717 34.56
2024-11-07BUY66037.69038.725 38.621USD 25,490 34.32
2024-11-06BUY8837.48038.050 37.993USD 3,343 34.05
2024-10-31BUY4432.53034.320 34.141USD 1,502 33.88
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SYRE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19150,5490167,62689.8%
2025-09-18178,64830220,25281.1%
2025-09-17159,1190352,78345.1%
2025-09-16184,7030266,49769.3%
2025-09-15299,4800417,88671.7%
2025-09-1281,49051168,74648.3%
2025-09-11112,7770279,76440.3%
2025-09-1054,522089,09161.2%
2025-09-0937,286066,99655.7%
2025-09-0861,946079,86577.6%
2025-09-0567,335081,17383.0%
2025-09-0496,0610191,41850.2%
2025-09-0369,863085,04882.1%
2025-09-0270,994262126,48756.1%
2025-08-2990,1750133,87767.4%
2025-08-2841,761083,86149.8%
2025-08-2798,551830114,39486.2%
2025-08-2686,505200129,15167.0%
2025-08-2581,3540129,79162.7%
2025-08-22128,3061,294195,18665.7%
2025-08-21177,0990235,89975.1%
2025-08-20292,17563329,03088.8%
2025-08-19194,1230236,21182.2%
2025-08-18135,9750161,81484.0%
2025-08-1564,986076,34785.1%
2025-08-1448,287068,69270.3%
2025-08-1390,6630110,58882.0%
2025-08-1247,2591158,73680.5%
2025-08-11125,5930144,62686.8%
2025-08-0874,973891,13682.3%
2025-08-07101,5360117,09486.7%
2025-08-06128,728120167,97576.6%
2025-08-0580,5740108,62874.2%
2025-08-0486,9960218,52439.8%
2025-08-01107,0590187,16157.2%
2025-07-31111,3235128,33786.7%
2025-07-30311,50616340,84091.4%
2025-07-2986,541099,79786.7%
2025-07-28112,4697156,41971.9%
2025-07-25198,18218543,01236.5%
2025-07-24106,594118290,77436.7%
2025-07-23117,0570135,18586.6%
2025-07-2286,970560141,88061.3%
2025-07-2198,6090111,72088.3%
2025-07-18100,1060106,28694.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy